Abstract |
Intravenous immunoglobulin ( IVIG) has been proposed as a treatment for toxic epidermal necrolysis (TEN) and Stevens-Johnson Syndrome (SJS). A number of retrospective and prospective studies have been conducted, with varying levels of evidence for the efficacy of IVIG. Recent publications provide opposing conclusions. A multi-center, comparative, long-term analysis needs to be conducted to determine the role of IVIG in the management of patients with SJS/TEN.
|
Authors | N Mittmann, B C Chan, S Knowles, N H Shear |
Journal | Skin therapy letter
(Skin Therapy Lett)
Vol. 12
Issue 1
Pg. 7-9
(Feb 2007)
ISSN: 1201-5989 [Print] Canada |
PMID | 17361314
(Publication Type: Journal Article, Review)
|
Chemical References |
- Immunoglobulins, Intravenous
|
Topics |
- Humans
- Immunoglobulins, Intravenous
(therapeutic use)
- Stevens-Johnson Syndrome
(drug therapy)
|